Detection of Metastatic Parathyroid Carcinoma With Tc-99m Sestamibi Imaging

PURPOSE:To assess the use of Tc-99m sestamibi to localize recurrent and metastatic parathyroid carcinoma. METHODS:A patient with a history of parathyroid carcinoma that was resected 6 months before had high serum calcium and high serum parathyroid hormone levels. Tc-99m sestamibi imaging was perform...

Full description

Saved in:
Bibliographic Details
Published in:Clinical nuclear medicine 1999-01, Vol.24 (1), p.21-23
Main Authors: AL-SOBHI, SAIF, ASHARI, LUAI H, INGEMANSSON, STIG
Format: Article
Language:English
Subjects:
Biological and medical sciences
Carcinoma - diagnostic imaging
Carcinoma - secondary
Carcinoma - surgery
Endocrine glands. Genital system. Mammary gland
Follow-Up Studies
Humans
Hypercalcemia - etiology
Hyperparathyroidism - etiology
Investigative techniques, diagnostic techniques (general aspects)
Lymphatic Metastasis - diagnostic imaging
Lymphatic Metastasis - pathology
Male
Medical sciences
Middle Aged
Neoplasm Recurrence, Local - diagnostic imaging
Parathyroid Neoplasms - diagnostic imaging
Parathyroid Neoplasms - pathology
Parathyroid Neoplasms - surgery
Parathyroidectomy
Radionuclide Imaging
Radionuclide investigations
Radiopharmaceuticals
Technetium Tc 99m Sestamibi
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:PURPOSE:To assess the use of Tc-99m sestamibi to localize recurrent and metastatic parathyroid carcinoma. METHODS:A patient with a history of parathyroid carcinoma that was resected 6 months before had high serum calcium and high serum parathyroid hormone levels. Tc-99m sestamibi imaging was performed to localize the recurrence. RESULTS:Tc-99 sestamibi imaging detected the recurrence and the metastatic lymph nodes. These findings were confirmed surgically and pathologically. CONCLUSION:Tc-99m sestamibi can be useful in diagnosing and localizing metastatic parathyroid carcinoma.
ISSN:0363-9762
1536-0229
DOI:10.1097/00003072-199901000-00005